In that study, the plasma level of lutein was inversely associated with IL-6 in serum from patients with coronary artery disease and lutein did also attenuate the release of inflammatory cytokines by lipopolysaccharide-treated peripheral blood mononuclear cells ex vivo. Here, IL6 is linked to coronary artery disorder.